Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.
Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.
Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.
In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.
Balchem (NASDAQ: BCPC) will hold a conference call on Tuesday, October 21, 2025 at 11:00 AM ET to review third quarter 2025 results. The company said results and accompanying financial exhibits will be released prior to the market open on October 21, 2025.
Management presenters are Ted Harris, Chairman, President and CEO, and Martin Bengtsson, CFO. Institutional investors and analysts can join by dial-in numbers provided, and the public may listen via a live webcast at https://events.q4inc.com/attendee/857727932. A replay will be available at the same link for one year after the call.
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer focused on health and nutrition markets, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference scheduled for September 9, 2025.
The company will be represented by key executives including Ted Harris (Chairman, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director of Investor Relations).
Balchem Corporation (NASDAQ: BCPC) reported strong Q2 2025 financial results with record net sales of $255.5 million, up 9.1% year-over-year. The company achieved net earnings of $38.3 million, a 19.4% increase, and record adjusted EBITDA of $69.2 million, up 11.2%.
All three business segments showed growth, with Human Nutrition and Health achieving record sales of $160.8 million (up 8.7%), Animal Nutrition and Health reaching $56.0 million (up 13.1%), and Specialty Products posting record sales of $37.2 million (up 6.0%).
Key developments include plans for a new $36 million micro-encapsulation facility in Orange County, NY, and the European Commission's implementation of 95.4% to 120.8% anti-dumping duties on Chinese choline chloride imports.
Balchem Corporation (NASDAQ: BCPC) has scheduled its second quarter 2025 financial results conference call for July 31, 2025, at 11:00 AM Eastern Time. The company's Chairman, President and CEO Ted Harris, along with CFO Martin Bengtsson, will host the call.
The Q2 2025 results will be released before market opening on the same day and will be available on www.balchem.com. Institutional investors and analysts can join by dialing 800-715-9871 (USA/Canada toll-free). A live webcast and replay will be accessible at the company's investor events portal.
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer focused on health and nutrition markets, has announced its participation in the upcoming CJS Annual New Ideas Summer Conference on July 10, 2025. The company will be represented by key executives including Ted Harris (Chairman, CEO, and President), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations).
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer focused on health and nutrition markets, has announced its participation in the upcoming Wells Fargo Industrials and Materials Conference scheduled for June 11, 2025. The company will be represented by key executives including Ted Harris (Chairman of the Board, CEO, and President), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) who will present at the conference.
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer focusing on health and nutrition markets, has announced its participation in the upcoming dbAccess Global Consumer Conference scheduled for June 4, 2025. The company will be represented by Ted Harris, who serves as Chairman of the Board, Chief Executive Officer, and President, along with Martin Bengtsson, the Chief Financial Officer.
Balchem (NASDAQ: BCPC) reported strong Q1 2025 financial results with record net sales of $250.5 million, up 4.5% year-over-year. The company achieved net earnings of $37.1 million, a 27.8% increase, and record adjusted EBITDA of $66.3 million, up 8.9% from the prior year quarter.
All three segments - Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products - showed sales and earnings growth. The Human Nutrition segment led with record sales of $158.5 million, while gross margin improved to 35.2%, up 120 basis points. Operating expenses decreased to $37.2 million, and free cash flow was $31.0 million.
The company maintains a strong financial position with $49.9 million in cash and continues to invest in growth initiatives despite global trade uncertainties.
Balchem (NASDAQ: BCPC) has released its 2024 Sustainability Report, highlighting significant progress in environmental and social initiatives. The company has exceeded its 2030 greenhouse gas emissions reduction target, achieving a 32% reduction from the 2020 baseline, surpassing the original 25% goal.
Key achievements include:
- Approximately 70% of revenue supports UN Sustainable Development Goals
- 15% reduction in water withdrawal compared to 2020 baseline
- Improved safety metrics with TRIR at 0.57 and LTIR at 0.21
- Fourth anniversary of commitment to UN Global Compact
CEO Ted Harris emphasized Balchem's dual focus on providing innovative health and nutritional solutions while maintaining excellence in stewarding people, communities, and shareholders. The company remains aligned with UN SDGs focusing on zero hunger, good health and well-being, and responsible consumption and production.
Balchem (NASDAQ: BCPC) has scheduled its first quarter 2025 financial results conference call for Thursday, April 24, 2025, at 11:00 AM Eastern Time. The event will be hosted by Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO.
The Q1 2025 results will be released before market opening on April 24, 2025, with the press release and financial exhibits available on www.balchem.com. Investors can join the call via toll-free number 1-877-407-8289 or local dial-in 1-201-689-8341.
A replay of the conference call will be accessible for three hours after conclusion until May 8, 2025, using dial-in numbers 1-877-660-6853 (toll-free) or 1-201-612-7415 (local) with conference ID #13753034.